Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Pre-prostatectomy Prostate Cancer
NCT01433913Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in prostate cancer (PCa), sponsored by National Cancer Institute. Started Nov 2011; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01433913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01433913.